本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mainz Biomed B.V.

3.53
+0.330010.31%
盤後3.50-0.0300-0.85%19:52 EDT
成交量:23.76萬
成交額:80.90萬
市值:1,072.72萬
市盈率:-0.16
高:3.58
開:3.24
低:3.14
收:3.20
資料載入中...
2025/03/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/11

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/11

SEC問詢函

Form CORRESP - Correspondence
2024/12/11

SEC問詢函

Form CORRESP - Correspondence
2024/12/09

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/09

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/11/05

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/10/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/04/09

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/04/07

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/01

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/05

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/01/24

SEC問詢函

CORRESP [Cover] - Correspondence
2022/01/24

SEC問詢函

CORRESP [Cover] - Correspondence
2022/01/21

招股説明書

F-1 - Registration statement for certain foreign private issuers